Skip to content

A prospective controlled study of autologous fat transplantation for breast reconstruction after breast cancer subcutaneous mastectomy

A prospective controlled study of autologous fat transplantation for breast reconstruction after breast cancer subcutaneous mastectomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056072
Enrollment
Unknown
Registered
2022-01-31
Start date
2022-01-31
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Group 1:Endoscopic surgery

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Female patients aged from 18 to 75 years; 2.Previous breast cancer patients who had undergone endoscopic subcutaneous adenectomy or traditional modified radical mastectomy; 3.No recurrence or metastasis within 2 years after systematic treatment; 4.Subjects voluntarily participated in the clinical trial and signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Pregnant women; 2.Patients with stage III or IV breast cancer at the time of diagnosis; 3.Patients who are too thin to extract enough fat; 4.Participated in clinical trials of other instruments or drugs within one month; 5.The patients could not tolerate the operation or voluntarily give up the operation because of the dysfunction of important organs such as heart, brain, lung and so on.

Design outcomes

Primary

MeasureTime frame
Survival rate of fat transplantation;Evaluation of breast appearance and patient satisfaction;

Countries

China

Contacts

Public ContactYinguang Gao

Beijing Friendship Hospital, Capital Medical University

gaoyinguang@163.com+86 13691099801

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026